139 related articles for article (PubMed ID: 25634638)
1. Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH₃) emitted by Pseudomonas aeruginosa.
Neerincx AH; Mandon J; van Ingen J; Arslanov DD; Mouton JW; Harren FJ; Merkus PJ; Cristescu SM
J Breath Res; 2015 Jan; 9(2):027102. PubMed ID: 25634638
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.
Carterson AJ; Morici LA; Jackson DW; Frisk A; Lizewski SE; Jupiter R; Simpson K; Kunz DA; Davis SH; Schurr JR; Hassett DJ; Schurr MJ
J Bacteriol; 2004 Oct; 186(20):6837-44. PubMed ID: 15466037
[TBL] [Abstract][Full Text] [Related]
3. Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa.
Gilchrist FJ; Alcock A; Belcher J; Brady M; Jones A; Smith D; Spanĕl P; Webb K; Lenney W
Eur Respir J; 2011 Aug; 38(2):409-14. PubMed ID: 21273393
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Pseudomonas aeruginosa hydrogen cyanide production by a polarographic approach.
Blier AS; Vieillard J; Gerault E; Dagorn A; Varacavoudin T; Le Derf F; Orange N; Feuilloley M; Lesouhaitier O
J Microbiol Methods; 2012 Jul; 90(1):20-4. PubMed ID: 22537820
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa Production of Hydrogen Cyanide Leads to Airborne Control of Staphylococcus aureus Growth in Biofilm and
Létoffé S; Wu Y; Darch SE; Beloin C; Whiteley M; Touqui L; Ghigo JM
mBio; 2022 Oct; 13(5):e0215422. PubMed ID: 36129311
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.
Enderby B; Smith D; Carroll W; Lenney W
Pediatr Pulmonol; 2009 Feb; 44(2):142-7. PubMed ID: 19148935
[TBL] [Abstract][Full Text] [Related]
7. SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients.
Lauridsen RK; Sommer LM; Johansen HK; Rindzevicius T; Molin S; Jelsbak L; Engelsen SB; Boisen A
Sci Rep; 2017 Mar; 7():45264. PubMed ID: 28349938
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the physiological relationship between the cyanide-insensitive oxidase and cyanide production in Pseudomonas aeruginosa.
Zlosnik JEA; Tavankar GR; Bundy JG; Mossialos D; O'Toole R; Williams HD
Microbiology (Reading); 2006 May; 152(Pt 5):1407-1415. PubMed ID: 16622057
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen cyanide, a secondary metabolite of Pseudomonas aeruginosa.
Castric PA
Can J Microbiol; 1975 May; 21(5):613-18. PubMed ID: 164997
[TBL] [Abstract][Full Text] [Related]
10. Isocitrate lyase supplies precursors for hydrogen cyanide production in a cystic fibrosis isolate of Pseudomonas aeruginosa.
Hagins JM; Locy R; Silo-Suh L
J Bacteriol; 2009 Oct; 191(20):6335-9. PubMed ID: 19700524
[TBL] [Abstract][Full Text] [Related]
11. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry--HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease.
Dummer J; Storer M; Sturney S; Scott-Thomas A; Chambers S; Swanney M; Epton M
J Breath Res; 2013 Mar; 7(1):017105. PubMed ID: 23445778
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Treerat P; Widmer F; Middleton PG; Iredell J; George AM
FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
Strateva T; Petrova G; Mitov I
J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
[TBL] [Abstract][Full Text] [Related]
14. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry.
Carroll W; Lenney W; Wang T; Spanel P; Alcock A; Smith D
Pediatr Pulmonol; 2005 May; 39(5):452-6. PubMed ID: 15765542
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen cyanide production by Pseudomonas aeruginosa at reduced oxygen levels.
Castric PA
Can J Microbiol; 1983 Oct; 29(10):1344-9. PubMed ID: 6318940
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
19. The effect of inorganic phosphate on cyanogenesis by Pseudomonas aeruginosa.
Meganathan R; Castric PA
Arch Microbiol; 1977 Jul; 114(1):51-4. PubMed ID: 20863
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection.
Smith D; Spaněl P; Gilchrist FJ; Lenney W
J Breath Res; 2013 Dec; 7(4):044001. PubMed ID: 24287489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
